Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Commercial Sponsor
PanTher Therapeutics and Avania Clinical
Scientific Title
A Phase I Study of PTM-101 as Neoadjuvant Therapy for Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)